These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4829933)

  • 1. Effect of ethidium bromide on elimination of exfoliative toxin and bacteriocin production in Staphylococcus aureus.
    Warren R; Rogolsky M; Wiley BB; Glasgow LA
    J Bacteriol; 1974 Jun; 118(3):980-5. PubMed ID: 4829933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of extrachromosomal deoxyribonucleic acid for exfoliative toxin production from phage group II Staphylococcus aureus.
    Warren R; Rogolsky M; Wiley BB; Glasgow LA
    J Bacteriol; 1975 Apr; 122(1):99-105. PubMed ID: 123526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nature of the genetic determinant controlling exfoliative toxin production in Staphylococcus aureus.
    Rogolsky M; Warren R; Wiley BB; Nakamura HT; Glasgow LA
    J Bacteriol; 1974 Jan; 117(1):157-65. PubMed ID: 4271807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemolysin and enzyme patterns of coagulase-positive staphylococci isolated from toxic epidermal necrolysis, Ritter's disease and impetigo contagiosa.
    Arbuthnott JP; Gemmell CG; Kent J; Lyell A
    J Med Microbiol; 1969 Nov; 2(4):479-87. PubMed ID: 4252396
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization and extrachromosomal control of bacteriocin production in Staphylococcus aureus.
    Jetten AM; Vogels GD
    Antimicrob Agents Chemother; 1973 Jul; 4(1):49-57. PubMed ID: 4791482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrachromosomal control of methicillin resistance and toxin production in Staphylococcus aureus.
    Dornbusch K; Hallander HO; Löfquist F
    J Bacteriol; 1969 May; 98(2):351-8. PubMed ID: 5192681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two serotypes of exfoliatin and their distribution in staphylococcal strains isolated from patients with scalded skin syndrome.
    Kondo I; Sakurai S; Sarai Y; Futaki S
    J Clin Microbiol; 1975 May; 1(5):397-400. PubMed ID: 126250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New type of exfoliatin obtained from staphylococcal strains, belonging to phage groups other than group II, isolated from patients with impetigo and Ritter's disease.
    Kondo I; Sakurai S; Sarai Y
    Infect Immun; 1974 Oct; 10(4):851-61. PubMed ID: 4139120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylococcal scalded skin syndrome: potentiation by immunosuppression in mice; toxin-mediated exfoliation in a healthy adult.
    Wiley BB; Allman S; Rogolsky M; Norden CW; Glasgow LA
    Infect Immun; 1974 Apr; 9(4):636-40. PubMed ID: 4822864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic determinants of trimethoprim resistance in a strain of Staphylococcus aureus.
    Nakhla LS
    J Clin Pathol; 1973 Sep; 26(9):712-5. PubMed ID: 4270921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage group II staphylococcal strains with chromosomal and extrachromosomal genes for exfoliative toxin production.
    Rogolsky M; Wiley BB; Glasgow LA
    Infect Immun; 1976 Jan; 13(1):44-52. PubMed ID: 129438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inhibitor of Staphylococcus aureus exfoliative toxin.
    Al-Sulami AA; Al-Rubiay KK; Affat AM
    East Mediterr Health J; 2001; 7(1-2):121-7. PubMed ID: 12596961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical syndromes caused by staphylococcal epidermolytic toxin.
    Edlich RF; Horowitz JH; Nichter LS; Silloway KA; Morgan RF
    Compr Ther; 1985 Apr; 11(4):45-8. PubMed ID: 3159536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and expression of the exfoliative toxin B gene from Staphylococcus aureus.
    Jackson MP; Iandolo JJ
    J Bacteriol; 1986 May; 166(2):574-80. PubMed ID: 3009410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological investigation of exfoliative toxin-producing Staphylococcus aureus strains in hospitalized patients.
    Piemont Y; Rasoamananjara D; Fouace JM; Bruce T
    J Clin Microbiol; 1984 Mar; 19(3):417-20. PubMed ID: 6232283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation with bacteriocin factors in staphylococci.
    Dastidar SG; Mitra S; Sarkar SN; Chakrabarty AN
    J Gen Microbiol; 1974 Oct; 84(2):245-52. PubMed ID: 4448977
    [No Abstract]   [Full Text] [Related]  

  • 17. The scalded-skin syndrome: relation to phage-group II staphylococci.
    Dajani AS
    J Infect Dis; 1972 May; 125(5):548-51. PubMed ID: 4260083
    [No Abstract]   [Full Text] [Related]  

  • 18. Microbiologic characteristics of exfoliative toxin-producing Staphylococcus aureus.
    Murono K; Fujita K; Yoshioka H
    Pediatr Infect Dis J; 1988 May; 7(5):313-5. PubMed ID: 3380582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative and quantitative methods for detecting staphylococcal epidermolytic toxin.
    Arbuthnott JP; Billcliffe B
    J Med Microbiol; 1976 May; 9(2):191-201. PubMed ID: 819654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and properties of a staphylococcin genetically controlled by the staphylococcal plasmid for exfoliative toxin synthesis.
    Rogolsky M; Wiley BB
    Infect Immun; 1977 Mar; 15(3):726-32. PubMed ID: 870429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.